Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for ...
Vendors Bank on the Prospect of Successful End-to-End Continuous Manufacturing for Biologics Continuous processing has been a mainstay in process industries for decades, but is conspicuously rare in ...
The company’s engineering heritage, combined with continuous investment in process automation and digital manufacturing, ...
A photo of technicians working in front of a process train. Novartis's continuous manufacturing center in Basel, Switzerland, replicates an end-to-end manufacturing process developed at the ...
Continuous manufacturing and a quality-by-design development approach are a natural fit. FDA, as well as other regulatory agencies around the world, have for many years been encouraging drug makers to ...
Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Continuous ...
Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. Within the process industry, the chemical and pharmaceutical ...
An intelligent manufacturing framework integrates robotics, IoT monitoring, and data analytics to optimize automotive production. The research ...
This workshop will discussed the business and regulatory concerns associated with adopting continuous manufacturing techniques to produce biologics, such as enzymes, monoclonal antibodies, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback